Low molecular weight species of tau in Alzheimer's disease are dependent on tau phosphorylation sites but not on delayed post-mortem delay in tissue processing

Neuroscience Letters

Volumn 399, Issue 1-2, 2006, Pages 106-110

  Santpere, Gabriel ^a   Puig, Berta ^a   Ferrer, Isidre ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Alzheimer disease; Brain bank; Post mortem delay; Tau; Truncated tau

Indexed keywords

PROTEIN ANTIBODY; SARCOSINE; SARKOSYL; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CADAVER; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; BINDING SITES; BRAIN; HUMANS; MOLECULAR WEIGHT; PHOSPHORYLATION; POSTMORTEM CHANGES; SPECIMEN HANDLING; TAU PROTEINS; TIME FACTORS;

EID: 33646091514     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.01.036     Document Type: Article

References (21)

1. Andreadis A., Brown W.M., and Kosik K.S. Structure and novel exons of the human tau gene. Biochemistry 31 (1992) 10626-10633
2. Arai T., Guo J., and McGeer P. Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J. Biol. Chem. 280 (2005) 5145-5153
3. Braak H., and Braak E. Temporal sequence of Alzheimer's disease related pathology. In: Peters A., and Morrison J.H. (Eds). Cerebral Cortex, vol. 14: Neurodegenerative and Age-related Changes in Structure and Function of Cerebral Cortex (1999), Kluwer Academic/Plenum Publishers, New York, Boston, Dordrecht 475-512
4. Canu N., Dus L., Barbato C., Ciott M.T., Brancolini C., Rinaldi A.M., Novak M., Cattaneo A., Bradbury A., and Calissano P. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18 (1998) 7061-7074
5. Chung C.W., Song Y.H., Kim I.K., Yoon W.J., Ryu B.R., Jo D.G., Woo H.N., Kwon Y.K., Kim H.H., Gwag B.J., Mook-Jung I.H., and Jung Y.K. Pro-apoptotic effects of tau cleavage product generated by caspase-3. Neurobiol. Dis. 8 (2001) 162-172
6. Fasulo L., Ugolini G., Visintin M., Bradbury A., Brancolini C., Verzillo V., Novak M., and Cattaneo A. The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J. Neurochem. 75 (2000) 624-633
7. Gamblin T.C., Chen F., Abraha A., Miller R., Fu Y., Garcia-Sierra F., Lagalwar S., Berry R.W., Binder L.I., and Cryns V.L. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10032-10037
8. García-Sierra F., Ghoshal N., Quinn B., Berry R., and Binder L.I. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J. Alzheimer's Dis. 5 (2003) 65-77
9. Goedert M., Spillantini M.G., Cairns N.J., and Crowther R.A. Tau-proteins of Alzheimer paired helical filaments-abnormal phosphorylation of all six brain isoforms. Neuron 8 (1992) 159-168
10. Goedert M., Spillantini M.G., Jakes R., Crowther F.A., Vanmechelen E., Probst A., Gostz J., Burki K., and Cohen P. Molecular dissection of the paired helical filament. Neurobiol. Aging 16 (1995) 325-334
11. Goedert M., Spillantini M.G., Jakes R., Rutherford D., and Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimers disease. Neuron 3 (1989) 519-526
12. Horowitz P.M., Patterson K.R., Guillozet-Bongaarts A.L., Reynolds M.R., Carroll C.A., Weintraub S.T., Bennett D.A., Cryns V.L., Berry R.W., and Binder L.I. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci. 24 (2004) 7890-7895
13. Ikeda K., Akiyama H., Arai T., Kondo H., Haga C., Iritani S., and Tsuchiya K. Alz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains. Neurosci. Lett. 258 (1998) 113-116
14. Johnson G.V., Seubert P., Cox T.M., Motter R., Brown J.P., and Galasko D. The protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 68 (1997) 430-433
15. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001) 1121-1159
16. Mercken M., Grynspan F., and Nixon R.A. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett. 368 (1995) 10-14
17. Novak M., Jakes R., Edwards P.C., Milstein C., and Wischik C.M. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5837-5841
18. Novak M., Kabat J., and Wischik C.M. Molecular characterisation of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 12 (1993) 365-370
19. Puig B., Rey M.J., and Ferrer I. Individual and regional variations of phospho-tau species in progressive supranuclear palsy. Acta Neuropathol. 110 (2005) 261-268
20. Skrabana R., Kontsek P., Mederlyova A., Iqbal K., and Novak M. Folding of Alzheimer's core PHF subunit revealed by monoclonal antibody 423. FEBS Lett. 568 (2004) 178-182
21. Wischik C.M., Novak M., Thogersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., and Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 85 (1998) 4506-4510